Article
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
JAMA - 19 May 2015
Ossenkoppele Rik, Jansen Willemijn J, Rabinovici Gil D, Knol Dirk L, van der Flier Wiesje M, van Berckel Bart N M, Scheltens Philip, Visser Pieter Jelle, Verfaillie Sander C J, Zwan Marissa D, Adriaanse Sofie M, Lammertsma Adriaan A, Barkhof Frederik, Jagust William J, Miller Bruce L, Rosen Howard J, Landau Susan M, Villemagne Victor L, Rowe Christopher C, Lee Dong Y, Na Duk L, Seo Sang W, Sarazin Marie, Roe Catherine M, Sabri Osama, Barthel Henryk, Koglin Norman, Hodges John, Leyton Cristian E, Vandenberghe Rik, van Laere Koen, Drzezga Alexander, Forster Stefan, Grimmer Timo, Sánchez-Juan Pascual, Carril Jose M, Mok Vincent, Camus Vincent, Klunk William E, Cohen Ann D, Meyer Philipp T, Hellwig Sabine, Newberg Andrew, Frederiksen Kristian S, Fleisher Adam S, Mintun Mark A, Wolk David A, Nordberg Agneta, Rinne Juha O, Chételat Gaël, Lleo Alberto, Blesa Rafael, Fortea Juan, Madsen Karine, Rodrigue Karen M, Brooks David J
Abstract excerpt
IMPORTANCE: Amyloid-β positron emission tomography (PET) imaging allows in vivo detection of fibrillar plaques, a core neuropathological feature of Alzheimer disease (AD). Its diagnostic utility is still unclear because amyloid plaques also occur in patients with non-AD dementia. OBJECTIVE: To us...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
